论文信息 - Immunisation at the crossroads: 9th National Immunisation/1st Asia–Pacific Vaccine Preventable Diseases Conference

Immunisation at the crossroads: 9th National Immunisation/1st Asia–Pacific Vaccine Preventable Diseases Conference

ber 1 • 3 January 2005 15 MJA • Volume 182 Num National Centre for Immunisation Research, Sydney, NSW. Peter B McIntyre, PhD, FRACP, FAFPHM, Director. Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC. Heath A Kelly, MPH, FAFPHM, Head, Epidemiology Unit. Royal Children’s Hospital, Melbourne, VIC. E Kim Mulholland, MD, FRACP, Director, Centre for International Child Health. Reprints will not be available from the authors. Correspondence: Associate Professor Heath A Kelly, Epidemiology Unit, Victorian Infectious Diseases Reference Laboratory, Locked Bag 815, Carlton South, VIC 3053. heath.kelly@mh.org.au The Medical Journal of Australia ISSN: 0025729X 3 January 2005 182 1 15-16 ©The Medical Journal of Australia 2005 www.mja.com.au Conference report was attended by more than 400 delegates, predomin Asia–Pacific region. A theme of the conference was th vaccines to achieve greater equity in health outcomes the Australian recommended immunisation sched vigorous discussion, highlighting the difficulty of d schedule that includes vaccines not funded for unive A stocktake of vaccination strategies and challenges

P. McIntyre | H. Kelly | E Kim Mulholland

[1] P. McIntyre,et al. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia. , 2004, Vaccine.

[2] Elizabeth Miller,et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction , 2004, The Lancet.

[3] Shabir A Madhi,et al. A role for Streptococcus pneumoniae in virus-associated pneumonia , 2004, Nature Medicine.

[4] S. Schrag,et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. , 2004, JAMA.

[5] J. McVernon,et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. , 2003, The Journal of infectious diseases.

[6] P. Horby,et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000 This report was written at the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) by: , 2002 .

[7] P. Horby,et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. , 2002, Communicable diseases intelligence quarterly report.

[8] S. Jaffar,et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants , 1997, The Lancet.